Website News and Research

RSS

Smart for Life introduces new THIN ADVENTURE Children's Weight Loss Program

With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.

29 Dec 2009

SU2C opens fully stocked online store to support cancer research

This is where the end of cancer begins… with the start of the New Year. Just in time for the New Year, Stand Up To Cancer (SU2C) is opening a fully stocked online store whose proceeds will support cancer research to bring new therapies to patients faster.

29 Dec 2009

CoachRx: An interactive website for CIGNA’s customers

As former Surgeon General C. Everett Koop, M.D. once said, “Drugs don’t work in patients who don’t take them.” That’s why CIGNA is introducing CoachRx, an interactive Web site to help CIGNA Home Delivery Pharmacy customers identify their personal barriers to taking their medications, and then providing ways to help people stay on track with the medications they need.

28 Dec 2009

Disability lawyers upgrade Social Security Disability Law website

As disability law firms throughout the country prepare for 2010 Social Security Disability application cases, the disability lawyers at Berry & Associates have gotten a head start with an upgrade to their website, nationaldisabilitylawyer.com.

28 Dec 2009

Michele Obama visits Children's National Medical Center

First Lady Michelle Obama read the holiday classic 'Twas the Night before Christmas by Clement Clarke Moore, during her holiday visit to Children's National Medical Center.

24 Dec 2009

Drug companies winners of the American prescription drug debate

On Dec. 15, the Obama Administration rejected a plan to allow the wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected intentions to take on the drug industry and secure cheaper prescription for Americans.

24 Dec 2009

Retractable Technologies wins patent infringement suit

Retractable Technologies, Inc. (“Retractable”) (AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Friday, December 18th in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian public company,) in favor of Retractable on all claims presented to the jury.

24 Dec 2009

Raptor Pharmaceutical completes $7.5 million registered direct offering

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.

24 Dec 2009

Achievements in lupus research, education and advocacy cause for celebration and hope

The year 2009 will be remembered as a year of many firsts for lupus, including the first successful phase III clinical trial of a potential new treatment for lupus, the launch of the first-ever Ad Council public awareness campaign for lupus, and the first comprehensive report on the barriers to lupus drug development. And it appears there are no signs of any slowing of momentum as we enter the New Year.

23 Dec 2009

Gene's role in immune system may suggest new treatments for childhood asthma

Pediatric researchers have identified a novel gene involved in childhood asthma, in one of the largest gene studies to date of the common respiratory disease. Because the gene, called DENND1B, affects cells and signaling molecules thought to be instrumental in the immune system overreaction that occurs in asthma, the discovery may have singled out an important target for new treatments.

23 Dec 2009

Food Safety News releases 2009 “Naughty” list, “Nice” list to follow

Food Safety News, the web-based newspaper that covers all things food safety, has published the first half of its 2009 Food Safety Naughty and Nice list. The website, which has had more than 75,000 unique visitors since its September, 2009 launch, compiled the list from stories it covered as well as input from the food safety community. The release of the finger-wagging “Naughty” list will be followed by a kudos-to “Nice” list, just in time for Santa’s sleigh.

23 Dec 2009

Cutting Edge Information: Top five research reports

As business intelligence firm Cutting Edge Information (http://www.cuttingedgeinfo.com) reflects on its accomplishments in 2009, the company pays special tribute to its five best-selling benchmarking research reports of the year by showcasing its top picks to the company's top supporters.

23 Dec 2009

National MS Society calls for grant applications to examine the impact of CCSVI hypothesis

2009 saw exciting research progress, unprecedented opportunities on the horizon, and more scientists than ever working on resolving important questions. Despite the year's economic and financial challenges, the National Multiple Sclerosis Society continues to propel research forward to end MS. In 2009 the Society provided over $33.5 million to support 345 new and ongoing projects in its research portfolio, plus $1.5 million for Fast Forward, the Society's drug development subsidiary which continues to attract new funding streams.

23 Dec 2009

Autism study and gene therapy in vision are top scientific achievements in 2009

A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.

23 Dec 2009

ARCA biopharma submits Gencaro trial protocol for review under the FDA’s SPA process

ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration’s (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company’s investigational, pharmacologically unique beta-blocker and mild vasodilator.

23 Dec 2009

Department of Health Information Standard awarded to CancerHelp UK and health information leaflets

Cancer Research UK's patient information website, CancerHelp UK, and its health information leaflets have been awarded the Department of Health Information Standard.

22 Dec 2009

Viral Genetics files updated Information Statement at www.pinksheets.com

Biotechnology company Viral Genetics today announced that it filed an updated Information Statement including unaudited consolidated financial statements for the nine months ended September 30, 2009, as well as year-end statements for December 31, 2008 and 2007.

22 Dec 2009

CPRIT extends Company Investment application date to January 12, 2010

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that it has extended the deadline to January 12, 2010 to file a letter of intent to submit a proposal for the Company Investment request for application (RFA). The RFA is available on the CPRIT website, www.cprit.state.tx.us/funding.html.

22 Dec 2009

Web-based CME courses to educate physicians on drug industry offered by FSMB Foundation

A new web-based Continuing Medical Education (CME) initiative by the Federation of State Medical Boards Foundation is seeking to educate physicians on various aspects of the relationship between the medical community and the pharmaceutical industry.

22 Dec 2009

Duane Reade offers H1N1 vaccines for New York residents

Duane Reade, the largest drug store chain in New York City, today announced that H1N1 vaccines are now available. As previously announced, Duane Reade pharmacies are providing New Yorkers with the H1N1 vaccine as part of the Company's commitment to servicing the health and wellness needs of the City's residents.

22 Dec 2009